Many preclinical models and studies support this thesis, as approximately 85% of sporadic BCCs have the inactivating mutation of PTCH1, and in UV-inducted in the PTCH1 mutant mice population, BCC incidence was spotted [112,113]. Here, PTCH1 is linked to skin basal cell carcinoma.